Close
FINDING CURES TOGETHER<sup>SM</sup>

FDA Expands Use of Antibody–Drug Conjugate to Additional Types of Lymphoma

This Cancer Research Catalyst blog post highlights the expanding use of the antibody–drug conjugate brentuximab vedotin (Adcetris) to include certain patients with two types of non-Hodgkin lymphoma.

AACR in the News

Blood test may help predict which breast cancers will recur

Associated Press reports on research about liquid biopsies presented at the San Antonio Breast Cancer Symposium.